Insmed to present at the 2025 goldman sachs annual global healthcare conference

Bridgewater, n.j. , may 28, 2025 /prnewswire/ -- insmed incorporated (nasdaq: insm), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the 2025 goldman sachs annual global healthcare conference in miami on wednesday, june 11, 2025, at 9:20 a.m.
INSM Ratings Summary
INSM Quant Ranking